7/22/2013

The inability of Medicare to negotiate drug prices contributes to increasing costs for all new drugs, writes Dr. Jonathan Walker of the Indiana University School of Medicine. The government allowed drugmakers to charge whatever price they want for medicines, he writes. Allowing some kind of negotiation is the most obvious solution to the problem, he writes.

Related Summaries